Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Damy, Thibaud ^a,b,c   Kirsch, Matthias ^a,c   Khouzami, Lara ^b,c   Caramelle, Philippe ^b,c   Le Corvoisier, Philippe ^a,b,c,d   Roudot Thoraval, Françoise ^a,c   Dubois Randé, Jean Luc ^a,b,c   Hittinger, Luc ^a,b,c   Pavoine, Catherine ^b,c   Pecker, Françoise ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

^c CNRS   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD SAMPLING; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; GLUTATHIONE DEFICIENCY; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEART VALVE REPLACEMENT; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN DEPLETION; TISSUE LEVEL; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHEMISTRY; CONGENITAL HEART MALFORMATION; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HOSPITALIZATION; MIDDLE AGED;

ANIMALIA;

ADULT; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; GLUTATHIONE; HEART ATRIA; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 63649139701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004871     Document Type: Article

References (37)

1. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, et al. (2002) Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39: 60-69.
2. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, et al. (2003) The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24: 442-463.
3. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, et al. (2007) Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49: 1733-1739.
4. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, et al. (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92: 1479-1486.
5. Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H (1997) Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J 61: 657-664.
6. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, et al. (1998) Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31: 1352-1356.
7. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, et al. (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102: 3060-3067.
8. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, et al. (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103: 2055-2059.
9. Mann DL (2002) Inflammatory mediators and the failing heart. Past, present, and the foreseeable future. Circ Res 91: 988-998.
10. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, et al. (2005) Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 111: 863-870.
11. Isaac DL (2008) Biomarkers in heart failure management. Curr Opin Cardiol 23: 127-133.
12. Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, et al. (2004) Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44: 1328-1333.
13. Morrow DA, de Lemos JA, Blazing MA, Sabatine MS, Murphy SA, et al. (2005) Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. Jama 294: 2866-2871.
14. Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, et al. (2008) Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. J Am Coll Cardiol 51: 2329-2335.
15. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA (2004) Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6: 289-293.
16. Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, et al. (2007) National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation 116: e99-109.
17. Garvin P, Nilsson L, Carstensen J, Jonasson L, Kristenson M (2008) Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. PLoS ONE 3: e1774.
18. Bourraindeloup M, Adamy C, Candiani G, Cailleret M, Bourin MC, et al. (2004) N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Circulation 110: 2003-2009.
19. Adamy C, Mulder P, Khouzami L, Andrieu-Abadie N, Defer N, et al. (2007) Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats. J Mol Cell Cardiol 43: 344-353.
20. Yucel D, Aydogdu S, Cehreli S, Saydam G, Canatan H, et al. (1998) Increased oxidative stress in dilated cardiomyopathic heart failure. Clin Chem 44: 148-154.
21. Haddad JJ, Harb HL (2005) L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)? Mol Immunol 42: 987-1014.
22. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI (2007) The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 113: 234-258.
23. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, et al. (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367.
24. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
25. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, et al. (2006) ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27: 1979-2030.
26. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27: 502-522.
27. Rahman I, Kode A, Biswas SK (2006) Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 1: 3159-3165.
28. Carnes CA, Janssen PM, Ruehr ML, Nakayama H, Nakayama T, et al. (2007) Atrial glutathione content, calcium current, and contractility. J Biol Chem 282: 28063-28073.
29. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, et al. (1998) Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97: 1536-1539.
30. Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115: 500-508.
31. Hill MF, Singal PK (1997) Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96: 2414-2420.
32. Lang CA, Mills BJ, Mastropaolo W, Liu MC (2000) Blood glutathione decreases in chronic diseases. J Lab Clin Med 135: 402-405.
33. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134: 489-492.
34. Amadou A, Nawrocki A, Best-Belpomme M, Pavoine C, Pecker F (2002) Arachidonic acid mediates dual effect of TNF-alpha on Ca(2+) transients and contraction of adult rat cardiomyocytes. Am J Physiol Cell Physiol 282: C1339-1347.
35. Cailleret M, Amadou A, Andrieu-Abadie N, Nawrocki A, Adamy C, et al. (2004) N-acetylcysteine prevents the deleterious effect of tumor necrosis factor-(alpha) on calcium transients and contraction in adult rat cardiomyocytes. Circulation 109: 406-411.
36. Defer N, Azroyan A, Pecker F, Pavoine C (2007) TNFR1 and TNFR2 signaling interplay in cardiac myocytes. J Biol Chem 282: 35564-35573.
37. Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, et al. (2008) N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 29: 625-631.